Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.830
+0.030 (1.67%)
At close: May 6, 2026, 4:00 PM EDT
1.830
0.00 (0.00%)
After-hours: May 6, 2026, 4:18 PM EDT
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $27.41 million as of May 6, 2026. Its market cap has decreased by -47.81% in one year.
Market Cap
27.41M
Enterprise Value
26.94M
1-Year Change
-47.81%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $27.41M, a decrease of -78.09%. That is a compound annual growth rate of -51.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 26.82M | 31.46% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 28.32M |
| Neuphoria Therapeutics | 28.12M |
| Polyrizon | 28.08M |
| Jasper Therapeutics | 27.64M |
| Celularity | 27.40M |
| Dyadic International | 27.39M |
| ABVC BioPharma | 26.69M |
| Outlook Therapeutics | 26.47M |